🇺🇸 FDA
Patent

US 11945794

Nuclear transport modulators and uses thereof

granted A61PA61P11/00A61P17/02

Quick answer

US patent 11945794 (Nuclear transport modulators and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Karyopharm Therapeutics Inc.
Grant date
Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P11/00, A61P17/02, A61P25/00, A61P25/28